^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HS-10502

    i
    Associations
    News

    Trials

    Company:
    Jiangsu Hansoh Pharma
    Drug class:
    PARP1 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors (NCT05740956)
    Phase 1
    Jiangsu Hansoh Pharmaceutical Co., Ltd.
    Recruiting
    Last update posted :
    10/11/2023
    Initiation :
    06/09/2023
    Primary completion :
    04/01/2026
    Completion :
    10/01/2026
    HRD • MUC16
    |
    HRD
    |
    HS-10502